Mr Leszek A Kolodziejczak, MD in Willimantic, CT - Medicare

Mr Leszek A Kolodziejczak, MD is a medicare enrolled "Surgery" physician in Willimantic, Connecticut. His current practice location is 162 Mansfield Ave., B, Willimantic, Connecticut. You can reach out to his office (for appointments etc.) via phone at (860) 423-5000.

Mr Leszek A Kolodziejczak is licensed to practice in Connecticut (license number 032557) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1689600561.

Contact Information

	Mr Leszek A Kolodziejczak, MD
	162 Mansfield Ave., B, Willimantic, CT 06226
	(860) 423-5000
	(860) 423-4838

Physician's Profile

Full Name	Mr Leszek A Kolodziejczak
Gender	Male
Speciality
Experience	Years
Location	162 Mansfield Ave., Willimantic, Connecticut
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Mr Leszek A Kolodziejczak attended and graduated from in

NPI Data:

NPI Number: 1689600561
Provider Enumeration Date: 06/23/2006
Last Update Date: 09/03/2019

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Mr Leszek A Kolodziejczak such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1689600561	NPI	-	NPPES
010032557CT01	Other	CT	ANTHEM BC / BS
030946	Other	CT	HEALTHNET
001325572	Medicaid	CT
001325572	Other	CT	BLUE CARE FAMILY PLAN
0811232	Other	CT	AETNA / US HEALTHCARE
9079072002	Other	CT	CIGNA
P469467	Other	CT	OXFORD
P04569	Other	CT	CHN
767225	Other	CT	CONNECTICARE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208600000X	Surgery	032557 (Connecticut)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Leszek A Kolodziejczak is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Leszek A Kolodziejczak, MD 5 Founders St, Ste 102, Willimantic, CT 06226-2050 Ph: (860) 423-5000	Mr Leszek A Kolodziejczak, MD 162 Mansfield Ave., B, Willimantic, CT 06226 Ph: (860) 423-5000

News Archive

Study examines link between higher screen time and bone mineral density in adolescents

Results of a study presented today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, showed that in boys, higher screen time was adversely associated to bone mineral density (BMD) at all sites even when adjusted for specific lifestyle factors.

Screening tool can help identify nations' vulnerability to Ebola

Public health experts can identify nations that are vulnerable to the occurrence and impact of future outbreaks of Ebola or other emergencies by using a screening tool that evaluates a nation's strengths across a wide range of measures such as political strength and health care capabilities, according to a new analysis from the RAND Corporation.

Protein thought to promote lymphoma by merely preventing cancer cells from dying appears to actively promote cancer cell growth

A protein previously thought to merely hinder the activity of a key cellular protein linked to cancer cell death, now appears to mimic the cellular signaling of that protein; potentially leading to the development of lymphoma.

Alnylam receives U.S. patent allowance for LNP platform

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application number 12/813,448, covering the company's proprietary second generation lipid nanoparticle (LNP) platform, including the "MC3" lipid.

BioSTAR biodegradable implant achieves comparable closure rates to Amplatzer ASO

A novel study by Canadian physicians reported that the BioSTARTM biodegradable implant achieved comparable closure rates to the Amplatzer Septal OccluderTM (ASO) in children with atrial septal defect (ASD). The BioSTAR device displayed successful outcomes, while avoiding issues associated with implants containing substantial amounts of metal.

Surgery Doctors in Willimantic, CT

Regina K Stuart, MD Surgery Medicare: Medicare Enrolled Practice Location: 5 Founders St Ste 102, Willimantic, CT 06226 Phone: 609-456-2898 Fax: 609-456-3078
Huseyin Nail Aydin, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 5 Founders St Ste 102, Willimantic, CT 06226 Phone: 203-907-7227
Francis Siracusa, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 90 Quarry St, Willimantic, CT 06226 Phone: 860-450-7222

Mr Leszek A Kolodziejczak, MD - Medicare in Willimantic, CT